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Getting Real About Essential Medicines: “The
Last Kilometer”
LUCIE WHITE†

I. INTRODUCTION
International law recognizes a person’s right to essential medicines as part of the individual’s overall human right to health. But what
does it take to realize this right? What does it take to deliver life-saving
medicines that “last kilometer,”1 from the pharmaceutical conglomerates in rich and emerging nations to the people who need them, often
with little bargaining power? At what point in the supply chain has
© 2016 Lucie White
† B.A., Radcliffe College, J.D., Harvard Law School. Lucie White is the Louis A. Horvitz
Professor of Law at Harvard Law School and Executive Committee member of the Harvard
Center for African Studies. The author wishes to acknowledge the student editors at the Maryland Journal of International Law who helped immeasurably in the research and editing of
the article, Peter Danchin and the others on the University of Maryland faculty who organized
the symposium, Clinical Trials and Access to Essential Medicines in African Countries, in
which the article was first presented, and the faculty at Harvard Law School and elsewhere
who offered comments on earlier drafts. Most of all, the author would like to acknowledge the
people in Ghana’s mental health treatment system and the mental health advocacy communities, particularly those people with mental health issues, whose commitment, vision, and courage have offered a vision of what a rights enhancing mental health system might be.
1. The “last kilometer” problem is often invoked in the global health context to illustrate
the challenges of ensuring actual access to essential medicines on the ground to the people
who need them, even those who are the hardest to reach or access. See, e.g., Hally Mahler et
al., Covering the Last Kilometer: Using GIS to Scale-Up Voluntary Medical Male Circumcision Services in Iringa and Njombe Regions, Tanzania, 3 GLOBAL HEALTH 503 (2015) (“The
global health community frequently invokes the concept of the ‘last mile’ or, in the case of
Tanzania, the ‘last kilometer’ to refer to achieving coverage for those clients who are the most
difficult to reach.”); Marc Gunther, Sue Desmond-Hellmann of the Gates Foundation Wants
an A-Plus, NONPROFIT CHRONICLES (Nov. 8, 2015), https://nonprofitchronicles.com/2015/11/08/sue-desmond-hellman-of-the-gates-foundation-wants-an-a-plus (“For
people who are interested in making a difference, the polio journey has a couple of learnings . . . . One is that technical tools aren’t enough. We have the technical tools. We have the
vaccine. On the other hand, getting that last kilometer, delivering the vaccine, getting it to
people in difficult areas . . . is the journey.”).
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enough been done? When the drug has been discovered? Manufactured? Made affordable, or shipped to the nation or region where it is
needed? When it has been distributed to clinics or to patients for the
first time? Or is it when the medication is given on an ongoing basis?
What does it actually take to realize the human right to essential medicines, and where should we draw the line? This essay poses this deceptively simple question.
We start with a story set in an almost middle income West African
nation with a stably democratic government and a good national health
care system.2 Assume that the right to essential medicines has been
both recognized by the nation’s law and implemented, at least in the
case of some drugs, within the nation’s borders.3 Thus, the government’s appropriate agency has composed a list of essential medicines
based on the World Health Organization’s (WHO) guidelines,4 deals
with pharmaceutical producers and suppliers have been cut, and actual
supplies of the drugs have arrived in the nation’s ports of entry. Assume further that the drugs in question are either free or inexpensive
because they are off-patent, readily available, and often deeply subsidized from international sources. According to a human rights analysis, has the right to essential medicines with respect to this drug been
achieved because the drug has been placed on the nation’s essential
medicines list, shipped inside its borders, and made available to the

2. This introductory narrative is a fictional composite that is loosely based on first-hand
experience that I have had over several years of work in West Africa as well as extensive
personal experience with mental health systems in well-resourced but highly unequal societies
like the United States. Subsequent parts of the essay occasionally draw on the specific legal
frameworks, policies, social contexts, and ground-level challenges facing Ghana in the context
of its dual commitments to universal access to essential medicines on the one hand and the
more comprehensive right to health on the other. I use Ghana as an exemplary nation in taking
on these dual challenges and in making substantial progress in responding to them. I have been
both instructed and inspired by Ghana’s global leadership in the mental health domain, in
particular, while at the same time, I cannot help but be reminded—from my work in Ghana
and the United States—of how long we have to go before we can fully realize these goals.
3. The World Health Organization provides guidance for countries in developing and
implementing national drug policies, highlighting “key components” of such policies like the
selection of essential drugs, affordability, financing, supply systems, regulations, rational use,
research, human resources development, and monitoring and evaluation. See WORLD HEALTH
ORGANIZATION [WHO], HOW TO DEVELOP & IMPLEMENT A NATIONAL DRUG POLICY (2d ed.
2001), http://apps.who.int/medicinedocs/pdf/s2283e/s2283e.pdf.
4. The WHO Expert Committee on the Selection and Use of Essential Medicines maintains and updates both the WHO Model List of Essential Medicines and WHO Model List of
Essential Medicines for Children, recommending “essential medicines” for different disease
classes. These recommendations are meant to serve as a guide for countries institutions in
forming their own essential medicines lists. See WHO Expert Comm. on the Selection & Use
of Essential Meds., The Selection & Use of Essential Medicines, 994 WHO TECHNICAL REP.
SERIES (2015).
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people who need it at an affordable cost?5
Yes and no. As the following story will show, to evaluate whether
peoples’ right to essential medicines has in fact been fully realized, we
must analyze the issue from where the people who need the drug actually stand.
II. A STORY
Let’s consider the issue from the perspective of an eighteen-yearold girl named “A,” an aspiring primary school teacher, who lives in
the north of the West African nation, about thirty kilometers west of
the nearest village with a cell phone tower and electrical power. Unlike
the thriving coastal region, this part of the nation is highly economically deprived. Indeed, families make ends meet by subsistence farming and remittances from family members. They suffer from many
health challenges, including undiagnosed cancer; mobility impairments from childhood polio; river blindness; respiratory problems
linked to cooking over charcoal fires; cholera and diarrhea from wastepolluted water; malaria; cardiovascular disease and diabetes linked to
development-driven lifestyle changes; chronic exhaustion linked to
farming in drought-parched soil; chronic severe depression; and other
debilitating mental health conditions.
Due to the remoteness of the village, A had walked fifteen kilometers a day for a decade to complete secondary school and planned
to travel south to seek work as a porter in the capital city’s sprawling
central market. However, her plans are interrupted, because over several weeks A becomes more and more agitated. She has racing thoughts
and her words start to rush together. She loses sleep. Eventually, her
behavior makes no sense at all, and she begins to threaten and strike
out at family members who try to calm her down.
Unsure of what to do, A’s family takes her to a local “prayer
camp” where the pastors use harsh herbs and violent rituals to control
her.6 Her family eventually brings her home and, without other recourse, secures her with a log in a shed behind their compound, as other

5. United Nations [U.N.] Econ. & Soc. Council, Comm. on Econ., Soc. & Cultural
Rights, General Comment No. 14: The Right to the Highest Attainable Standard of Health
(Article 12 of the International Covenant on Economic, Social, and Cultural Rights), ¶ 12,
U.N. Doc. E/C.12/2000/4 (Aug. 11, 2000) [hereinafter General Comment No. 14].
6. See generally HUMAN RIGHTS WATCH, LIKE A DEATH SENTENCE 30–36 (2012),
https://www.hrw.org/sites/default/files/reports/ghana1012webwcover.pdf.
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families have done to manage the same situation. Troubled by this “option,” they talk with many people in the area and decide to risk a journey to the government clinic in the district capital—a village just over
fifty kilometers away where doctors are said to have “real drugs” that
can make their daughter quiet. They borrow a motor bike and, through
great effort, confine her in order to make the journey. So what happens
when they get there? There are several possibilities:
The clinic could be closed due to a shortage of staff.
The clinic could be open, but, with staff who lack basic mental
health training.
Or the clinic could have a visiting nurse on staff with some basic
mental health training who visits the clinic once a week.
If A’s family chooses to wait, then the nurse might arrive. She
might then tell them to go back to the prayer camp and be patient, or
to see a traditional healer in her village. She could also say that A’s
condition is “manic depression” and direct them to the psychiatric hospital in the capital city on the coast, some fourteen hours to the south
by bus. There, A might become an “inmate,”7 who at times is confined
in a large open space with thirty others who have similar conditions.
A might occasionally be cared for by dedicated nurses, but the hardpressed psychiatrists who work in the nation’s public mental health
system, would be far too busy to devote much time to her care.8
Alternatively, instead of sending the family to the city, the nurse
who occasionally visits the community clinic might agree to help them.
She might start by asking for the family’s national health insurance
card to pay for the treatment A will receive. The family is not enrolled
7. In Ghana, mental health patients are commonly referred to as “inmates” despite the
country putting forth reforms meant to address such stigma. Even though the law itself has
changed, it takes public education—and time—for such changes to become common parlance
across the population, especially in dispersed areas of the country. See, e.g., Masahudu Ankiilu
Kunateh, Inmates of Pantang Hospital Get Free NHIS Cards, GHANAIAN CHRON. (Jan. 24,
2013), http://thechronicle.com.gh/inmates-of-pantang-hospital-get-free-nhis-cards; Mental
Health Inmates Deserve Dignity - Activists, GHANA NEWS AGENCY (Oct. 12, 2015),
http://www.ghananewsagency.org/health/mental-health-inmates-deserve-dignity-activists95606. See generally, IRIN, Ghana’s New Mental Health Bill Aims to Address Stigma,
GUARDIAN
(Aug.
29,
2011),
http://www.theguardian.com/global-development/2011/aug/29/ghana-new-mental-health-bill.
8. For example, Ghana was reported to be spending only 1.4% of its total health expenditures on mental health in 2011 and that low level of services was found to be concentrated
in the urban areas, leaving virtually no resources in more rural areas. Mark Roberts et al., An
Overview of Ghana’s Mental Health System: Results from an Assessment Using the World
Health Organization’s Assessment Instrument for Mental Health Systems (WHO-AIMS), INT’L
J. MENTAL HEALTH SYS. (May 4, 2014), http://www.ijmhs.com/content/8/1/16.
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in the health insurance scheme, however, because they cannot afford
the annual premium. Yet the nurse does not know that she should not
have asked for the card at all since mental health services are supposed
to be free to everyone, whether or not a person is enrolled in the national health insurance scheme.9
Among the essential medicines to which A may be legally entitled
to10 for manic depression (or bipolar mania, as the doctors call it) is
lithium, a naturally occurring element that is inexpensive for the government to obtain and is readily available—though not always used—
in the capital city to the south. Yet even so, in the far northern government clinics where A is likely to be taken, the drug is often not there.
Or if the clinic has the drug available, the nurse might not know
that it will help A. Or if she does know, she may not remember the
dosage she should give to avoid a toxic overdose. Alternatively, if the
nurse does know how much of the drug to give A, she might not be
able to let her patient stay in the clinic overnight and thus must send
her away with a bottle of pills to take when she gets home. But in either
case, neither the clinic nor A’s family will have the equipment, or the
technical training, to monitor her blood levels on a regular basis so as
to protect against toxicity in the future. Thus, without access to followup testing, A might become very sick. Or she might die.
But before this scenario even happens, it is more likely that her
family will stop giving her the drug. They might then take her back to
the clinic to have the nurse sort things out, which, without equipment
and know how, she won’t be able to do. They might take her back to a
prayer camp. Or they might secure her in the shed once more, releasing
her under their guard to do house chores when they can.

9. For example, although people are entitled to free mental health care under the terms
of Ghana’s Mental Health Act of 2012 § 88 (Act No. 846/2012), the National Health Insurance
Act further provides that “a person with mental disorder” is exempted from paying to enroll
in the National Health Insurance Scheme (NHIS) and is entitled to the NHIS’s health benefits
as a member. National Health Insurance Act § 29(c) (Act No. 852/2012) (Ghana).
10. For example, people enrolled in Ghana’s National Health Insurance Scheme are entitled to certain essential psychiatric medications under the terms of that program. See National
Health Insurance Act § 33(1) (declaring that the National Health Insurance Scheme Medicine
List shall be “derived from the Essential Medicines List approved by the Minister,” which in
turn is based off the WHO’s Model List of Essential Medicines); Benefits Package, NAT’L
HEALTH INS. SCHEME (Ghana), http://www.nhis.gov.gh/benefits.aspx (last visited Apr. 12,
2016) (listing NHIS’s benefits and excluding medicines not on the NHIS Medicines List).
Compare NHIS Medicines List, NAT’L HEALTH INS. SCHEME (Ghana),
http://www.nhis.gov.gh/medlist.aspx (last visit Apr. 12, 2016) (listing medicines covered by
the NHIS), with MINISTRY OF HEALTH: GHANA NATIONAL DRUGS PROGRAMME, GHANA
ESSENTIAL MEDICINES LIST (6th ed. 2010).
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International human rights groups or investigative journalists
might then come to A’s family home, or the homes of others like them,
to expose A’s plight as a human rights violation typified by her failure
to receive an essential medicine that she should have been entitled to.
Those groups might note that, while A was thus deprived of her basic
rights, the drug that she needed was in plentiful supply. For it is easier
for such commentators, or accusers, to portray the story’s end as a human rights wrong than to map out the systemic failures that the chain
of “perpetrators” confronts along the way.11
III. HUMAN RIGHTS VIOLATIONS?
The story of A is a story of multiple failings, not in the performance of individuals or corporate entities, but in the institutions and
systems that failed to deliver the medicine that “last kilometer” to the
people who need them. To some degree these failings can be attributed
to a shortage of money and the human competencies required to perform needed mental health roles.12 Yet it is not just a question of
money. It is also a question of how the money and people that can
reasonably be made available can be woven together into synergistic
systems of care.
A. Promoting the Right to Essential Medicines: A Systems
Perspective
The point of this paper is that if we are serious about realizing the
right to essential medicines, we must evaluate that right to essential
11. This paragraph, as well as the following, suggest not just the need for systemic analysis in order to identify the causes of, and point toward potential remedies for, ostensible “human rights violations.” The paragraph also suggests that conventional economic and social
rights analyses, when it fails to do a systemic analysis, ends up blaming not so much the victim,
but those actors in a complex bureaucracy, like the nurses, psychiatrists, or family, in A’s
situation, who are doing their very best to respond to her needs with critically limited resources
which are themselves only forthcoming within the context of inadequate delivery systems.
Such a scenario can be deemed as an example of “structural violence,” which has been defined
as the following:
The term “structural violence” is one way of describing social arrangements that put individuals and populations in harm’s way. The arrangements are structural because they are embedded in the political and economic organization of our social world; they are violent because
they cause injury to people (typically, not those responsible for perpetuating such inequalities).
With few exceptions, clinicians are not trained to understand such social forces, nor are we
trained to alter them. Yet it has long been clear that many medical and public health interventions will fail if we are unable to understand the social determinants of disease.
Paul Farmer et al., Structural Violence and Clinical Medicine, 3 PLOS MED. 1686, 1686–87
(2006).
12. WHO, MENTAL HEALTH LEGISLATION & HUMAN RIGHTS 6 (2003),
http://www.who.int/mental_health/resources/en/Legislation.pdf.
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medicines from rights holders’ perspectives. We must not just count
the sale price of pills on the shelves. Rather, we must do the much
harder work of keeping an eye on the pills as we contrast the journeys
of rights holders through existing systems of care against optimal ones.
Did those people end up getting the medicines they were entitled to on
an ongoing basis? If not, what didn’t they get? And where did the system break down? It is at these points of system breakdown, in situ,
where the human rights violations lie.
Viewing human rights realization from such a systemic perspective is crucial for many reasons. Among the most important is that a
“smart” change in system design can save a lot of money in contexts
where money is short13; conversely, a very large increase in budget will
have little impact without the system’s capacity to “absorb” those
funds in productive ways.14
B. Why Start with A?: “From Margin to Center”15
Why start with A’s case in an essay arguing that the right to essential medicines must be understood in systemic terms? Isn’t her
chronic mental illness at the margins of the whole concept of essential
medicines? For instance, shouldn’t we be starting our analysis with
malaria or Ebola, i.e., those infectious diseases that put us at risk of
widespread epidemics and for which we need a pharmaceutical cure?
Indeed, what do we gain by centering our analysis of essential
13. See, e.g., Bella English, In Rwanda, Visionary Doctor Is Moving Mountains Again,
BOSTON.COM
(Apr.
13,
2008),
http://archive.boston.com/news/world/articles/2008/04/13/in_rwanda_visionary_doctor_is_moving_mountains_again (discussing Paul
Farmer’s work in Rwanda, where a primary care system that used community-based paramedics in a thoughtful way both greatly improved quality and saved valuable resources at the same
time).
14. In the context of global health aid, Jeffrey Sachs argues against the notion that a
health sector’s insufficient “absorptive capacity” with respect to lacking infrastructure and
capital can render excess aid futile. Rather, keeping those system constraints in mind, such aid
can be used to address those constraints or channeled in alternative ways to further the provision of health care. JEFFREY SACHS, THE END OF POVERTY 274 (2005).
15. BELL HOOKS, FEMINIST THEORY: FROM MARGIN TO CENTER (1984). We have used
A’s case as a lens similar to the lens adopted by noted radical feminist Bell Hooks (also known
as Gloria Watkins), using her experiences living in black America, in order to assess central,
systemic issues in the eyes of one who experiences the negative effects of those issues at the
outskirts of the system. As Hooks wrote in the preface to her book Feminist Theory:
To be in the margin is to be part of the whole but outside the main body . . . . Living as we
did—on the edge—we developed a particular way of seeing reality. We looked from both the
outside in and the inside out. We focused our attention on the center as well as the margin. We
understood both. This mode of seeing reminded us of the existence of a whole universe, a main
body made up of both margin and center.
Id. at ix.
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medicines on A’s situation? The answer is simply this: expanding the
concept of essential medicines to respond to A’s treatment needs will
help us expand our understanding of what kinds of “medicines,” in its
holistic meaning, are required for all health conditions, even those that
are wrongly perceived to respond to one-time chemical treatment
alone.
So what are the features of mental health conditions that challenge
our limited conception of “medicine” for all health conditions?16 Four
of these features stand out. First, since its origins, the policy of listing
essential medicines has focused on infectious diseases generally occurring in previously colonized regions. Such diseases were believed
to cause widespread epidemics if the infected person was not either
isolated from others or cured through chemical intervention. Mental
health conditions, in contrast, often benefit from drugs, but only in the
context of ongoing practices of family and community-embedded care.
Second, though our core concept of essential medicines has finally begun to expand to include drugs for noncommunicable diseases (NCDs)
like diabetes, arteriosclerosis, and cancer, those diseases are too often
considered treatable by “miracle” drugs like insulin, rather than
through drugs in the context of comprehensive care. We have seen that
mental health conditions, without exception, require treatment in the
context of networks of ongoing care. Third, unlike both infectious diseases and NCDs, mental health conditions are not yet perceived to be
somatic. Yet since they are, in fact, both somatic and more, they challenge the rigid division between that part of the person that can be
treated with “medicines” and that part which is outside their scope.
Fourth, mental health conditions are highly stigmatized across many
cultures. Indeed, many mental health conditions are widely believed to
be afflictions of character or spirit rather than body. They thus impose
stigma on caretakers, taxing their courage, as well as patience, in profound ways. Though this feature of mental health conditions may be
viewed as unique, this shadow of stigma has and continues to affect
the experience and concept of illness itself, and the caretakers who respond to afflicted people’s needs.
In conclusion, let us imagine bringing these four features of mental health conditions from the “margin to center” in our analysis of the
“medicine” required to treat all health conditions, even those which at
first glance appear to fit most tightly into the predominant paradigm.
Consider Ebola. A vaccine and effective antiviral medications will
16. The following stereotypes are based on my own practical experience with mental
health advocacy and broad knowledge of both stereotypes and realities surrounding it.
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help, but the disease afflicts more than the body of the infected person
alone. It also affects the wellbeing and resilience of the patient and her
family and community in comprehensive ways. It cannot be either contained or effectively treated unless there are longer term drug treatments; community-based preventative and responsive practices; education and awareness to combat stigma; and both patience and courage
among the many affected people.
C. The Right to Drugs / The Right to Care: A Call for Pragmatic
Action
Thus, I take the hard case of A’s bipolar condition to challenge
and contribute to the reframing of the right to essential medicines from
rights holders’ perspectives in the following way. Let us start by reframing human rights and “economic and social rights,” like the right
to essential medicines in particular, as something other than lists of
discrete pharmaceutical products. Let us understand that right not as a
tangible thing, but as a call to action. Let us understand that right not
just as a call to action but as a call for pragmatic action—a call for
specific, feasible steps that people can take together in various ways.
Let us understand pragmatic action as action that addresses the treatment challenge from the bottom up and top down, so as to connect
people with what they need to maintain wellbeing, even while sick, not
through drugs alone, but through drugs within systems of care.
I will contribute to this reframing in the following way. First, I
will show how the concept of essential medicines since its origins has
been constrained within a formalistic frame. Second, I will show how
the dominant frame for understanding human rights has been similarly
formalistic. Thus, rather than nudging our understanding of health
rights toward pragmatic action, the convergence of human rights doctrine and essential medicines policy has undermined that goal. Third, I
will show how the movement for HIV/AIDS treatment, specifically in
the context of antiretroviral (ARV) drugs, finally reframed the right to
essential medicines from a formalistic conception into a call for social
movement and pragmatic action for change. Next, I will discuss the
limits and potential of the HIV treatment access movement from the
perspective of both HIV-affected individuals and people like A affected by other health conditions. Finally, I will show how a public
health movement that embeds within it the right to essential medicines
can transform the demand for “access to essential medicines” into a
call—and a movement—for holistic systems of care.
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1. On Essential Medicines
The concept of essential medicines has, from its origins, been
constrained within a formalistic frame. It had its modern origins in the
aftermath of World War I, when the WHO was founded.17 Since then,
the WHO has developed the concept in a more and more detailed way.
This effort reached a turning point in 1977, when the WHO first issued
an annual list of recommended essential medicines, along with the recommendation that individual nations draw from this list to create their
own lists of essential medicines to respond to their own contexts.18
Each nation was then to use its list to inform a range of specific health
policy decisions, from determining which drugs would be available
free of charge in public hospitals and clinics, to which drugs would be
reimbursed by public insurance and subsidy programs, to similar policies. Over 150 nations have now opted into this essential medicines
scheme.19
The WHO compiles its official essential medicines list on the basis of a cost/benefit calculus that takes account of factors that include
cost; comparative effectiveness; safety; ease of dispensing and use;
and the like.20 The list is revised every two years as new drugs reach
the market, older drugs become less expensive, the disease burden
shifts, and the calculus’s bottom line therefore changes.21 The WHO’s
most recent list was issued in April 2015.22 Its listed drugs cover the
full range of common medical conditions for both infectious and noncommunicable diseases and major mental health conditions. It would
be a remarkable global health accomplishment for all of the drugs on
the WHO list to be actually available and effectively administered on
17. John Charles, Origins, History, and Achievements of the World Health Organization,
2 BRIT. MED. J. 293, 294 (1968).
18. Richard Laing et al., 25 Years of the WHO Essential Medicines Lists: Progress and
Challenges, 361 LANCET 1723, 1723 (2003). WHO’s conception of essential medicines has
evolved over time, initially defined as those medicines that were “of utmost importance, basic,
indispensable and necessary for the health and needs of the population.” Id. Today, essential
medicines are recognized as “those that satisfy the priority health care needs of the population
and “are selected with due regard to public health relevance, evidence on efficacy and safety,
and comparative cost-effectiveness.” Essential Medicines, WHO, http://www.who.int/topics/essential_medicines/en/ (last visited Apr. 29, 2016).
19. Laing, supra note 18.
20. WHO, WHO Medicines Strategy: Revised Procedure for Updating WHO’s Model
List of Essential Drugs, annex, WHO Doc. EB109/8 (Dec. 7, 2001), http://apps.who.int/medicinedocs/documents/s22165en/s22165en.pdf.
21. See, e.g., WHO Moves to Improve Access to Lifesaving Medicines for Hepatitis C,
Drug-Resistant TB and Cancers, WHO (May 8, 2015), http://www.who.int/mediacentre/news/releases/2015/new-essential-medicines-list/en.
22. WHO Expert Comm. on the Selection & Use of Essential Meds., supra note 4, annex
I.
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a regular basis to all people in need of them, in rural as well as urban
areas, low income as well as affluent regions, powerful as well as less
powerful enclaves, all over the globe. Needless to say, this is not the
case, nor do WHO’s health policy strategists expect that such a highlevel intervention, taken alone, ought to be sufficient to produce that
result.23
2. On Human Rights
This history might also be traced back to the World War I era, but
its defining moment came at the close of World War II, when, under
the guidance of Eleanor Roosevelt and others, the Universal Declaration of Human Rights24 was drafted.25 In this defining moment, the idea
of a right to health was not treated at length. Nonetheless, the document
created the foundational text—the constitutional framework—on
which the International Covenant of Economic, Social, and Cultural
Rights (ICESCR) subsequently codified a formal right to health in
greater detail in its Article 12.26 The Covenant placed the legal burden
on nation states to take steps to “progressively realize” the right to
health to the degree that they are able to under the circumstances.27
The ICESCR was itself explicated in great detail in the highly

23. See generally WHO, supra note 3. As the WHO has recognized:
These problems [of lack of access to essential drugs, poor quality, and irrational
use] have persisted despite all the work done to improve access to essential drugs,
to ensure drug quality and to promote rational drug use. The reasons are complex
and go beyond simple financial constraints. To understand them it is necessary
to look at the characteristics of the drug market, and to study the attitudes and
behavior of governments, prescribers, dispensers, consumers and the drug industry. Health sector development, economic reform, structural adjustment policies,
trends towards liberalization, and new global trade agreements all have a potential impact on the pharmaceutical situation in many countries. They may also
affect the ultimate goal of achieving equity in health.
Id. at 4.
24. G.A. Res. 217 (III) A (Dec. 10, 1948).
25. History of the Document, U.N., http://www.un.org/en/sections/universal-declaration/history-document/index.html (last visited Apr. 13, 2016).
26. G.A. Res. 2200A (XXI), annex, at 51 (Dec. 16, 1966).
27. Id. at 49 (“Each State Party to the present Covenant undertakes to take steps, individually and through international assistance and co-operation, especially economic and technical, to the maximum of its available resources, with a view to achieving progressively the
full realization of the rights recognized in the present Covenant by all appropriate means, including particularly the adoption of legislative measures.” [emphasis added]); Hans V.
Hogerzeil & Zafar Mirza, THE WORLD MEDICINES SITUATION 2011: ACCESS TO ESSENTIAL
MEDICINES AS PART OF THE RIGHT TO HEALTH § 1.1.1–.3, WHO (2011),
http://apps.who.int/medicinedocs/documents/s18772en/s18772en.pdf (summarizing the bases
for the legal enforceability of the right to health in the ICESCR and the right to essential medicines that stem from that).
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significant General Comment No. 14: The Right to the Highest Attainable Standard of Health (Art. 12) (Comment No. 14).28 This document
makes clear that accessible, affordable, and high quality medicines required for persons to achieve the highest attainable standard of health,
including essential medicines, be made available to all according to the
Comment No. 14’s and ICESCR’s terms.29 Thus, the promulgation in
2000 of Comment No. 14 marks a convergence of the right to health
and essential medicines domains. Embedding the essential medicines
policy into a broader right to health movement might now seem obvious. Yet at the time that the right to health was codified, it was not
understood to intersect directly with the WHO’s listing of essential
medicines. Nor was an intersection between the two domains a focus
of advocates’ attention. Indeed, as essential medicines has gradually
become a key health right for advocates to fight for, as well as a complex inventory for experts to compose, scholars and activists alike have
thought hard about the value of this linkage.
Since the promulgation of Comment No. 14, the challenge of “implementation” has too often been deferred.30 When it hasn’t, the most
common method for incentivizing implementation has been using
checklists of “indicators” that can be feasibly assessed on a national or
international scale.31 Thus, research might assess how many of a sample of a nation’s essential medicines it has on hand, and the cost to the
government of each. Although one might say that this sort of monitoring is better than nothing, it bears noting that the focus of this monitoring of implementation is not from the rights holders’ perspectives,
but from the vantage point of the nation state and international entities
that produce and control the supply. Another illustration of this supplyside bias in implementation advocacy is the almost exclusive focus
among essential medicine advocates, particularly lawyers, on features
of international intellectual property regimes—notably the requirements in international trade agreements for the transnational enforcement of pharmaceutical patents—that have kept the cost of many drugs

28. General Comment No. 14, supra note 5.
29. Id. ¶¶ 4, 12(a).
30. This gap is now widely recognized and a major focus of academic and pragmatic
attention. See generally KATHARINE G. YOUNG, CONSTITUTING ECONOMIC AND SOCIAL RIGHTS
(2012) (elaborating why it is so difficult for courts to adjudicate economic and social rights
claims in ways that succeed in “getting the food on the table” and how creative constitutional
courts, such as those in South Africa, India, and Colombia, have crafted different kinds of
remedies that have overcome this challenge).
31. See, e.g., WHO, USING INDICATORS TO MEASURE COUNTRY PHARMACEUTICAL
SITUATIONS: FACT BOOK ON WHO LEVEL I AND LEVEL II MONITORING INDICATORS 1–2 (2006),
http://www.who.int/medicines/publications/WHOTCM2006.2A.pdf.
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on essential medicines lists exorbitantly high.32
Although it goes without saying that this work is very important,
it must be noted it crowds out other kinds of scholarly and advocacy
work. First, this heavy focus on intellectual property issues shifts attention away from other important domains where human rights issues
can arise, such as the drugs that are excluded—or included—on a nation’s list, and the law, policy, and politics through which the WHO
and national lists are composed. Second, this emphasis on intellectual
property issues can narrow the framing of the social movement for essential medicines away from “the last kilometer,” i.e., the daunting issues of law and human rights that must be addressed to get essential
drugs—even those that are on all the lists, not covered by patent protections, and already in a nation’s port city—into rights holders’ hands.
Although launching a social movement for essential medicines
that is framed by human rights might seem like an unequivocal plus,33
when the dominant, formalistic understanding of human rights guides
the building of the movement, this turn to human rights in the essential
medicines context has a few downsides. One cluster of costs has to do
with the tactical limits that a human rights framework can impose on
an essential medicines movement. For instance, a human rights framework can—but need not—preclude other normative framings, like
public health or moral duty. It can narrow the attention of lawyers and
other advocates to a limited and sometimes highly technical range of
values, laws, and strategies.34 This framework can also work, perversely, to excuse a failure to get drugs to those who need them: for,
some human right advocates might argue, so long as the nation has
complied with its duty to endorse the sacred “list” and procure the
drugs, then the right has been fulfilled. Furthermore, a human rights
framework, in any context, including essential medicines, can demobilize and ramp down what might be a powerful social movement by
channeling people’s energy into writing reports, appearing before official commissions, filing lawsuits, and the like, rather than more robust forms of protest.

32. See, e.g., Brook K. Baker, Patents, Pricing, and Access to Essential Medicines in
Developing Countries, 11 VIRTUAL MENTOR 527, 528 (2009).
33. Fran Quigley, The Trans-Pacific Partnership and Access to Medicines, HEALTH &
HUM. RTS. J. (June 18, 2015), http://www.hhrjournal.org/2015/06/the-trans-pacific-partnership-and-access-to-medicines.
34. See generally DAVID KENNEDY, The International Human Rights Movement: Part of
the Problem?, in THE DARK SIDES OF VIRTUE: REASSESSING INTERNATIONAL
HUMANITARIANISM 3–35 (2004).
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The second set of costs of a human rights framework for an essential medicines movement has to do with the stylized roles within
which the framework confines the actors who are involved. One commentator has described these roles as the savages, victims, and saviors.35 In this schema, the “victims,” those who need essential medicines, are configured as sickly, weak, passive people who are incapable
of feeling anger, not to mention channeling that anger into concerted
political action. They are thus deemed unable to analyze challenges
strategically; identifying overlapping interests, including those that
they share with adversaries; mapping the actors’ powers and vulnerabilities; creating politically savvy relationships, linkages, and coalitions; and using human rights rhetoric and strategies deliberately, so as
to make use of their power.36 This formidable array of capacities is
suppressed rather than enhanced by the “victim script” in which human
rights discourse locks them.37
The savages-victims-saviors schema also traps the “saviors,” or
the coalitions of doctors, lawyers, and academics, for instance, into a
paternalistic, humanitarian stereotype, no matter what their actual intentions might be.38 This humanitarian script has been trenchantly
traced to images of colonial settings, endemic with killer diseases,
where soldiers worked hand-in-hand with doctors to save the native
peoples to work in the mines.39
Finally, the savage-victim-savior schema blocks the capacity and
motivation of all in the triad to analyze the complex structural and institutional architecture of the pharmaceutical industry and other actors—from global to local—which are part of the reason that the drugs
are not there. This “savage” script that human rights framing40 can imply does little, in the end, to generate broad and rich ideas. For as noxious as a system that uses money to entice the innovation of drugs for
elites while poor people die, even this space offers sites for reform. For
instance, incentives for drug innovation need not come exclusively
from the rights holders’ own market power. It might come from human
35. Makau Mutua, Savages, Victims, and Saviors: The Metaphor of Human Rights, 42
HARV. INT’L L.J. 201 (2001).
36. See generally Jeremy Perelman & Lucie White, Stones of Hope: Experience and Theory in African Economic and Social Rights Activism, in STONES OF HOPE: HOW AFRICAN
ACTIVISTS RECLAIM HUMAN RIGHTS TO CHALLENGE GLOBAL POVERTY 149–71 (Lucie White
& Jeremy Perelman eds., 2011).
37. See generally Mutua, supra note 35, at 203–204, 228–233.
38. See generally id. at 204, 233–242.
39. Jeremy Greene et al., Colonial Medicine and Its Legacies, in REIMAGINING GLOBAL
HEALTH 38 (Paul Farmer et al. eds., 2013).
40. See generally Mutua, supra note 35, at 202–203, 219–227.
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rights strategists’ shaming; competition from public suppliers; philanthropic grants; global funds; negotiated G8 contributions; consumer
and shareholder pressure; or an upsurge of direct social movement for
change.41 As easy, and satisfying, as it feels to just “blame big pharma,”
the slogan does not always lead to creative political action.
A further problem arises when the concept of essential medicines
is changed into a human rights movement because of a foundational
tension embedded in the human rights concept itself. This is the tension
between first generation “negative” rights, on the one hand, and the
much more problematic second generation “positive” rights on the
other.42 For example, it might be considered a clear first generation human rights violation for a nation to discriminate against women or
other vulnerable groups in the distribution of a limited supply of essential medicines.43 Or it might be considered a human rights violation
for the government to obstruct the delivery of essential medicines to
areas with large communities of ethnic or religious minorities.44 Or it
might be considered a violation for the government to withhold an essential medicine from an imprisoned journalist to inflict extreme
pain—or torture—in addition to imprisonment for her opposition of
41. See, e.g., William Forbath, Cultural Transformation, Deep Institutional Reform, and
ESR Practice: South Africa’s Treatment Action Campaign, in STONES OF HOPE: HOW AFRICAN
ACTIVISTS RECLAIM HUMAN RIGHTS TO CHALLENGE GLOBAL POVERTY 51–90 (Lucie White &
Jeremy Perelman eds., 2011) (describing the movement in South Africa to require the government to provide free ARVs to pregnant women in order to block HIV transmission to their
newborns).
42. Negative rights are those rights also considered to be civil liberties such as the freedom from torture, freedom of speech, freedom of the press, freedom of religion, freedom to
assemble, and the like. These are called “negative” because they are believed to require the
state to refrain from taking action that harms citizens or limits their fundamental liberties,
while positive rights are the “economic and social rights” that are believed to require the state
to act affirmatively, generally by spending money, in order to provide people the goods required for their survival, well-being, and thriving as human beings. See INTERNATIONAL
HUMAN RIGHTS IN CONTEXT: LAW, POLITICS, MORALS 186 (Henry Steiner et al. eds., 3d ed.
2007).
43. See, e.g., Ellen Barry & Celia W. Dugger, India to Change Its Decades-Old Reliance
on Female Sterilization, N.Y. TIMES (Feb. 20, 2016), http://www.nytimes.com/2016/02/21/world/asia/india-to-change-its-decades-old-reliance-on-female-sterilization.html (discussing recent efforts in India to make additional forms of birth control publically available for women, a shift from its historical reliance on state-sponsored sterilization
through tubal ligation).
44. See, e.g., Stephanie Nebehay et al., U.N. Fears for Hundreds of Thousands if Syria
Troops Encircle Aleppo, REUTERS (Feb. 9, 2016), http://www.reuters.com/article/us-mideastcrisis-syria-un-idUSKCN0VI0T8 (covering the cutting off of humanitarian aid to citizens by
Syrian government-led troops encircling the rebel-held city of Aleppo); Jane Perlez, Death
Stalks Muslims as Myanmar Cuts Off Aid, N.Y. TIMES (May 2, 2014), http://www.nytimes.com/2014/05/03/world/asia/death-stalks-muslims-as-myanmar-cuts-off-aid.html (detailing the cutting off of humanitarian aid and medical care by the Buddhist-led Myanmar
government as part of a larger crackdown against the country’s Ronhingya Muslim minority).
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the government.45 In all of these examples, the state uses its control
over the essential medicines supply to violate one of a person’s clearly
established “first generation” human rights. Such exploitation of the
essential medicines framework to make it a vehicle for violating the
most fundamental human rights of citizens is clearly an outrage, if not
also, in some cases at least, an actionable crime.
Yet it is much more difficult for human rights discourse to be deployed to target the background economic and social conditions—
summed up in poverty—that obstruct the ground-level realization of
the “human right” to getting high quality essential medicines in the
context of effective essential care. For indeed, efforts of advocates to
“stretch” human rights discourse to help deliver discrete commodities
like housing or education have been very challenging.46 Further efforts
to deploy human rights tools to secure complex systems of care are
unquestionably on the cutting edge of human rights advocacy.47 But
little progress on this front has yet been made.
3. On HIV, MSF, and Global Poverty
Public awareness of essential medicines increased in the 1980s
and 1990s in the context of the AIDS crisis. Social movement arose,
particularly in South Africa and the United States, as ARVs were developed but made unavailable to HIV-positive low income people, particularly in sub-Saharan Africa.48 Eventually, after intensive organizing by South Africa’s Treatment Action Campaign (TAC), the South
African Constitutional Court issued a landmark decision, Minister of
Health v. TAC,49 which required the South African government to
make Nevirapine, an ARV, available to HIV-infected pregnant women

45. See, e.g., China’s Ailing Prisoners, WALL ST. J. (June 29, 2015),
http://www.wsj.com/articles/chinas-ailing-prisoners-1435595053 (reviewing the denial of
medical treatment to reporter Gao Yu and other Chinese political prisoners by their government).
46. See, e.g., Government of the Republic of South Africa v. Grootboom 2001 (1) SA 46
(CC) (demonstrating the difficulties of the South African Constitutional Court in delivering
housing to citizens claiming fundamental rights to housing even though both the Constitution
and the Court itself recognized their formal entitlement to that right).
47. See, for instance, the efforts of the Colombian Constitutional Court to use its remedial
powers in creative ways to compel the government to reform the entire institutional structure
of the nation’s health system. See Helena Alviar García, Distribution of Resources Led By
Courts: A Few Words of Caution, in SOCIAL AND ECONOMIC RIGHTS IN THEORY AND PRACTICE:
CRITICAL INQUIRIES 67–81 (Helena Alviar García, Karl Klare, & Lucy A. Williams, eds.,
2015). See generally YOUNG, supra note 30.
48. Mark Heywood, South Africa’s Treatment Action Campaign: Combing Law and Social Mobilization to Realize the Right to Health, 1 J. HUM. RTS. PRAC. 14, 17–19 (2009).
49. Minister of Health v. Treatment Action Campaign (2002) (5) SA 721 (CC).
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to prevent the infection of their newborn children.50 Energized by this
victory, this social movement expanded to address killer infectious diseases in low income nations more broadly. Social movement campaigns promoting drug treatment, universal vaccination, vaccine development, and disease eradication for the major infectious disease
drugs emerged across the globe.51 These campaigns helped to transform WHO’s essential medicines policy into a social movement that,
for all of their inherent limits, would nonetheless soon become framed
in human rights terms. Because of the cost of patented ARV drugs in
South Africa and elsewhere, the intellectual property questions became
a major, and needed, focus of both legal strategy and social movement
action.
A turning point in this HIV-prompted social movement for essential medicines came in 1999, when Médecins Sans Frontières (MSF),
or Doctors without Borders, earned a Nobel Prize and then decided to
use the funds it was awarded to launch its own essential medicines
movement.52 In the early 2000s, WHO began to issue its own guides to
essential medicines advocacy.53 Since then scholars like Thomas
Pogge54 and Jeffrey Sachs55 and philanthropists like Bill and Melinda
50. Id. ¶ 135.
51. See, e.g., Involving Everyone: Social Mobilization Is Key in an Ebola Outbreak Response in Guinea, WHO (May 2014), http://www.who.int/features/2014/social-mobilisation/en (describing direct community outreach efforts to educate Guineans affected by Ebola
outbreaks); STOP TB PARTNERSHIP, ADVOCACY, COMMUNICATION AND SOCIAL MOBILIZATION
SUBGROUP AT COUNTRY LEVEL, ADVOCACY, COMMUNICATION AND SOCIAL MOBILIZATION TO
STOP TB, WHO Doc. WHO/HTM/STB/2006.37 (2006), http://www.stoptb.org/assets/documents/resources/publications/acsm/tb-advocacy.pdf (laying out a ten-year strategic framework for advocacy, communication, and social mobilization to combat the spread of tuberculosis); Maxine A Whittaker et al., Advocating for Malaria Elimination - Learning from the
Successes of Other Infectious Disease Elimination Programmes, 13 MALARIA J. (June 5,
2014), http://malariajournal.biomedcentral.com/articles/10.1186/1475-2875-13-221 (reviewing the lessons of “globally-coordinated elimination advocacy campaigns” for infectious diseases and how they can be applied towards the elimination of malaria).
52. About Us, MEDECINS SANS FRONTIERES ACCESS CAMPAIGN, http://www.msfaccess.org/the-access-campaign (last visited Mar. 15, 2016).
53. See, e.g., WHO, WHO MEDICINES STRATEGY: FRAMEWORK FOR ACTION IN ESSENTIAL
DRUGS AND MEDICINES POLICY 2000-2003, WHO Doc. WHO/EDM/2000.1 (2000),
http://apps.who.int/medicinedocs/pdf/whozip16e/whozip16e.pdf.
54. See generally Thomas W. Pogge, Eradicating Systemic Poverty: Brief for a Global
Resources Dividend, 2 J. HUM. DEV. 59 (2001); Thomas W. Pogge, Human Rights and Global
Health: A Research Program, 36 METAPHILOSOPHY 182 (2005) [hereinafter Pogge, Human
Rights and Global Health].
55. See generally Millennium Promise: About Us, MILLENNIUM VILLAGES PROJECT,
http://millenniumvillages.org/millenniumpromise (last visited May 5, 2016) (overviewing
Millennium Promise, an organization co-founded by Jeff Sachs, which “believe[s] that poverty
in all its forms can be eliminated by 2030, even in the most challenging and remote places in
the world”).
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Gates56 have launched a comprehensive movement to combat global
poverty. The most urgent issue in their campaigns has been the unconscionable mortality rate in less developed nations from the major infectious diseases, notably malaria, tuberculosis, and AIDS.57 Eventually, the United Nations appointed a Special Rapporteur on Extreme
Poverty to consolidate these efforts.58
It can be seen that even as HIV and global poverty movements
energized the confluence of human rights and essential medicines, the
movement’s focus remained upstream. That focus did not shift from
blockages in the sourcing of affordable drugs, like intellectual property
constraints, to the even more challenging issues that arise along the
“last kilometer,” between the last links in the supply chains and the
rights holders’ hands. Rather, and ironically perhaps, even as the HIV
movement’s demand for universal access to ARV medication went viral, so to speak, its focus remained upstream, instead of on the ground.
One final upshot of the upstream focus of the essential medicines/human rights social movement is that the focus on unblocking
sources of costly drugs through international lawyering and geopolitical activism has unintentionally entrenched a magical landscape in
which miracle drugs can zap “real” diseases, while noncommunicable,
chronic, lifestyle-linked, and especially mental health conditions are
less worthy of activists’ time. We must redraw that landscape, so that
all health conditions, from mental illness to malaria to HIV, are treated
rather than zapped, through networks of care.

56. See generally What We Do, BILL & MELINDA GATES FOUND., http://www.gatesfoundation.org/What-We-Do (last visited May 5, 2016) (describing the work of the Bill & Melinda
Gates Foundation’s Global Development Division: “Nearly 2.5 billion people worldwide live
on less than US$2 a day, and more than 1 billion suffer from chronic hunger. For these people,
the basics of food, water, shelter, and sanitation are in short supply, and healthcare and education can be unaffordable luxuries. Our Global Development Division aims to identify and fund
high-impact solutions that can help hundreds of millions of people lift themselves out of poverty and build better lives.”).
57. See Pogge, Human Rights and Global Health, supra note 54, at 182–84; Global Fund
Overview, GLOBAL FUND, http://www.theglobalfund.org/en/overview/ (last visited Mar. 15,
2016) (describing the fund as a “partnership organization designed to accelerate the end of
AIDS, tuberculosis and malaria as epidemics”). See generally Marcella M. Alsan et al., Poverty, Global Health and Infectious Disease: Lessons from Haiti and Rwanda, 25 INFECTIOUS
DISEASE CLINICS N. AM. 611 (2011) (exploring the association between poverty and communicable disease based on the authors’ experiences in Haiti and Rwanda).
58. See Special Rapporteur on Extreme Poverty and Human Rights, U.N. OFF. HIGH
COMMISSIONER
FOR
HUM.
RTS.
[OHCHR],
http://www.ohchr.org/EN/Issues/Poverty/Pages/SRExtremePovertyIndex.aspx (last visited
Mar. 15, 2016).
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D. Recalling Alma Ata
Eventually the HIV crisis brought home to essential medicines/human rights activists that it takes more than unblocking drug
supplies at the international and national levels in order to ensure that
essential medicines reach the rights holders who need them. When
health systems and rights holders are under-resourced, sometimes dispersed across wide areas, and in need of drug regimes embedded in
long-term treatment practices—when all of these challenges are there,
as they almost always are—then it takes more than formal lists, patent
overrides, inspiring court decisions, and global activists’ fervor to get
those treatments transmuted into ongoing care. South Africa was confronted by this multiplex challenge in implementing the spirit as well
as the letter of their Constitutional Court’s landmark decision in Minister of Health v. TAC in order to get ARVs to all the entitled rights
holders in need.59
In this context, a separate history of insight and action about public health system design has been recovered and mined. This history
began at the 1978 International Conference on Primary Health Care
held in Alma Ata, in what is now Kazakhstan but was then part of the
former Soviet Union.60 At this path breaking conference, representatives from developing and other nations came together to synthesize
insights from a plethora of experimental practices in under-resourced
regions. Their goal was to articulate a plural vision of health care delivery systems for multiple under-resourced settings. The common
theme in this vision would be three grounding elements. The first was
strong state responsibility for the funding and oversight of each nation’s primary care-based health system. The second was the integration of all three tiers of the system (i.e., primary, secondary, and tertiary care). The third was the creative design of primary health care
institutions, networks, and networks of community engagement on the
ground.61
The Alma Ata vision thus drew on innovations in primary health
59. See Nathaniel Bruhn, Litigating against an Epidemic: HIV/AIDS and the Promise of
Socioeconomic Rights in South Africa, 17 MICH. J. RACE & L. 181, 201–2, 206–7, 209–10
(2011); Lisa Forman, Ensuring Reasonable Health: Health Rights, the Judiciary, and South
African HIV/AIDS Policy, 33 J.L. MED. & ETHICS 711, 720 (2005).
60. Joint Report of the Director-General of the WHO and the Director of the UNICEF,
Primary Health Care: Report of the International Conference on Primary Health Care (Sept.
1978) [hereinafter Joint Report].
61. WHO & U.N. Children’s Fund [UNICEF] International Conference on Primary
Health Care, Declaration of Alma-Ata art. V–VIII (Sept. 1978), http://www.who.int/publications/almaata_declaration_en.pdf [hereinafter Declaration of Alma-Ata].
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care from China, Latin America, and other areas over prior decades, in
which patients, families, community members, “barefoot” medical
workers, trained paraprofessionals, and highly schooled medical professionals were drawn into working together to create virtuous circles
of care.62 The Alma Ata vision was inspired by a politics of both populist participation and social movement activism.63 It endorsed an expansive interpretation of the United Nations’ formal commitment to a
universal right to health.64 Yet at the same time the conference participants also endorsed key features of “western” health systems, like its
conception of professional expertise, its technologies, and its listings
of essential medicines medications.65 Indeed, the Alma Ata Declaration’s section VII, subpart 3, after listing several political and economic essentials of exemplary PHC systems, states that all of these
systems must “at least” include the universal “provision of essential
drugs.”66
The Alma Ata vision for primary health care institutional design
has been put into practice in several contemporary settings, with remarkable results. These settings include Partners in Health co-founder
Paul Farmer’s community-based primary health care clinics in Haiti,
Rwanda, the urban United States, Ebola-affected Sierra Leone, and
elsewhere. True to Alma Ata’s call for system integration, all of these
clinics were nested in the host nations’ public health systems.67 Such
settings also include South Africa’s “treatment literacy” programs.

62. See Fran Baum, Health for All Now! Reviving the Spirit of Alma Ata in the TwentyFirst Century: An Introduction to the Alma Ata Declaration, 2 SOC. MED. 34, 34 (2007); Marcos Cueto, The Origins of Primary Health Care and Selective Primary Health Care, 94 AM.
J. PUB. HEALTH 1864, 1864–66 (2004).
63. Id.
64. See OHCHR & WHO, THE RIGHT TO HEALTH: FACT SHEET NO. 31 9–10 (2008),
http://www.ohchr.org/Documents/Publications/Factsheet31.pdf. Compare Declaration of
Alma-Ata, supra note 61 (reiterating and specifying the Conference’s goals of achieving
“health for all” or “health care for all” throughout) with G.A. Res. 2200A (XXI), annex, supra
note 26.
65. See, e.g., Joint Report, supra note 60, ¶¶ 73, 130, 133. See generally NITSAN CHOREV,
THE WORLD HEALTH ORGANIZATION BETWEEN NORTH AND SOUTH 87–93, 97–98 (2012) (discussing the history of compromise between the aspirational goals of Alma Ata and Western
industry prerogatives in the Declaration’s endorsement of “appropriate” technology transfer
and essential drugs lists).
66. Declaration of Alma-Ata, supra note 61, art. VII(3).
67. See generally Betsy McKay, West Africa Struggles to Rebuild Its Ravaged HealthCare System, WALL ST. J. (June 4, 2015), http://www.wsj.com/articles/africa-struggles-to-rebuild-its-ravaged-health-care-system-1433457230. Dr. Paul Farmer—a Harvard professor and
co-founder of the Boston-based charity Partners in Health—has been recently immersed in the
challenge of combating the Ebola virus in conjunction with the governments of Liberia, Sierra
Leone, and Guinea, which for years have all been racked by civil wars, coups, and unrest. Id.
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These were grassroots education, peer support, and empowerment programs linked with government primary health care centers, mostly in
rural areas, which distributed ARVs. These treatment literacy sites
could become catalysts for transforming the primary health centers in
which they were situated from within.68 These programs were created
to draw HIV-positive clinic patients into participatory educational programs to enable them to adhere to complex ARV regimes. Yet the programs’ protocols were more elaborate, drawing all of the clinics’ stakeholders, including all patients, HIV-positive or not, providers, and
community members into linked practices of care. In recent years, the
WHO, health systems think tanks, university-based public health
scholars, and others have explicitly recalled Alma Ata in creating
health systems in challenging settings, such as post-conflict nations
and stressed urban areas.69 With regard to essential drugs, it is increasingly becoming accepted that it is in Alma Ata’s vision for primary
health care design, rather than the formal pronouncement, that the right
to essential medicines, from rights holders’ perspectives at least, is
likely to come within reach.
E. An Unrealized Potential
Alma Ata’s significance to the essential medicines as human
rights movement is increasingly recognized. Yet the Alma Ata vision
could have done more. For the essential medicines and human rights
convergence has failed to challenge either the skewed priorities of the
essential medicines policy concept or the dysfunctions embedded in
primary health care institutional design. Instead of either of these two
potential priorities, the essential medicines and human rights social
movement has focused on universal access to drugs for infectious diseases, especially in sub-Saharan Africa. As we saw above, the first
such disease that the movement targeted was AIDS. It then expanded
its focus to drugs for two other major infectious diseases, malaria and
tuberculosis. Then, in the context of the global poverty movement, the
movement has begun to campaign to make treatments for waterborne
68. See generally Heywood, supra note 48, at 17–19.
69. See, e.g., Baum, supra note 62, at 40; Max Cooper et al., Post-Conflict Healthcare
Reconstruction: Yemen and the Window of Opportunity for Primary Care, J. GLOBAL HEALTH
(Apr. 1, 2015), http://www.ghjournal.org/post-conflict-healthcare-reconstruction-yemen-andthe-window-of-opportunity-for-primary-care (evoking the Alma Ata Declaration while recommending Yemen focus on primary care as a post-conflict developing state); Nikolaos
Oikonomou & Anargiros Mariolis, How Is Greece Conforming to Alma-Ata’s Principles in
the Middle of Its Biggest Financial Crisis?, 60 BRIT. J. GEN. PRAC. 456, 456–57 (2010) (overviewing the problems of Greek’s health system in rural, regional, and urban areas and recommending that it more fully embrace and adhere to the Alma Ata Declaration’s emphasis on
primary care).
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infectious diseases available as well.70
At the same time that activists have thus kept drugs for the killer
infectious diseases at the center of their attention, a number of factors,
including widespread unconscious bias, have kept the need for sustained drug treatment for NCDs at the margins. For though it is often
left unsaid, pernicious and mistaken beliefs that NCDs are linked to
negative lifestyle choices and moral flaws pervade public consciousness.71 Patients with NCDs are sometimes viewed to have less social
utility than the “worthy” children, youth, and able-bodied adults often
falsely believed to be most vulnerable to infectious diseases.72 At the
same time, treatment for NCDs must often be sustained over time. It is
sometimes only partially effective and requires great patience to provide. Over time even the most inexpensive drugs required to treat some
of these diseases—such as insulin and the supplies needed to administer it on a daily basis—can become quite expensive, while the drugs
for other NCDs such as cancer remain totally out of reach.73
Because of this combination of an explicit focus by essential medicines/human rights activists on infectious diseases and a simultaneous
marginalization in public consciousness of NCDs, the need for Alma
Ata-inspired primary care innovations—which would put the features
of NCD treatment at its center—has been too often overlooked.74
70. See Alsan et al., supra note 57; Joia Mukherjee, Cholera in Haiti: Another Disease
of Poverty in a Traumatized Land, PARTNERS IN HEALTH (Oct. 22, 2010),
http://www.pih.org/blog/cholera-in-haiti-another-disease-of-poverty-in-a-traumatized-land
(describing cholera’s connections to poverty and Partner In Health’s efforts to combat cholera
and waterborne diseases in Haiti).
71. See Jacquineau Az. . .tsop & Tisha R. Joy, Epistemological and Ethical Assessment
of Obesity Bias in Industrialized Countries, 6 PHIL. ETHICS & HUMAN. MED. (Dec. 16, 2011),
http://www.peh-med.com/content/6/1/16; Jens Seeberg & Lotte Meinert, Can Epidemics Be
Noncommunicable?: Reflections on the Spread of ‘Noncommunicable’ Diseases, 2 MED.
ANTHROPOLOGY THEORY 54, 56–57, 60 (2015).
72. See WHO First Ministerial Conference on Healthy Lifestyles and Noncommunicable
Disease
Control,
Conference
Proceedings,
at
12
(Apr.
2011),
http://www.who.int/nmh/events/moscow_ncds_2011/conference_documents/conference_report.pdf; Anthony Maher & Devi Sridhar, Political Priority in the Global Fight against Non–
Communicable
Diseases,
2 J.
GLOBAL HEALTH
(Dec.
2012),
at
4,
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529321/pdf/jogh-02-020403.pdf.
73. See generally Dele Abegunde, ESSENTIAL MEDICINES FOR NON-COMMUNICABLE
DISEASES (NCDS), at 11–19, 23, WHO (2011), http://apps.who.int/medicinedocs/documents/s19716en/s19716en.pdf (overviewing the cost burdens and accessibility issues of essential medicines for diabetes, cancer, and other conditions in the developing world and advocating the development of evidence-based clinical guidelines to promote the appropriate use
and prescribing of NCD medicines); David J. Hunter & K. Srinath Reddy, Noncommunicable
Diseases, 369 NEW ENG. J. MED. 1336, 1340–41 (2013).
74. Alessandro R. Demaio et al., Primary Health Care: A Strategic Framework for the
Prevention and Control of Chronic Non-Communicable Disease, 7 GLOBAL HEALTH ACTION
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How would Alma Ata-inspired primary health care work for
NCDs? The answer is straightforward. Such a primary health care setting would provide the multi-dimensional systems of ground-level patient education, peer support, professional back-up, and care that
would enhance complex drug treatment while empowering patients,
family, communities, and providers to work together to share, and enhance, everyone else’s care. Without such systems, neither patients nor
essential others get the medication, treatments, support, or ecosystems
of caring others that they need for both specifically diagnosed conditions and overall well-being.
Thus, if the essential medicines/human rights activists want to
catch up, they will have to bring the margin of NCDs and mental health
conditions back into the center of essential medicines/human rights
concerns, as feminist scholar Bell Hooks advised in the context of
black women’s feminist movement.75 Essential medicine human rights
advocates will have to join with treatment system scholars and activists76 to create effective networks of care. To face up to these challenges, they will have to work through several tensions in human rights
discourse itself. Some of these tensions draw from trends I have already identified above.
The first tension arises when treatment is reduced by human
rights and essential medicines scholars/activists to the ingestion of a
thing, one product, or one pill in a market basket of economic and social goods. Yet, to put it simply, getting pills inside people’s bodies,
without more, will not necessarily give them the treatment they require. In fact, simply putting pills into people’s bodies outside the context of systems of care, risks being perceived as unhelpful, intrusive,
or even violent.
The second tension arises around the question of scale of the essential medicines problem. The tendency here is to impose a rigid conceptual separation across different “levels” of political space tasked
with addressing this issue based on different governmental jurisdictions, in the terms set by current international and domestic laws. In
(Aug. 4, 2014), http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122819/pdf/GHA-724504.pdf (recognizing the “paucity of guiding frameworks for legislative measures” to address death and disability caused by NCDs and advocating a primary health care approach to
the problem).
75. See HOOKS, supra note 15.
76. See generally Jim Yong Kim, Paul Farmer, & Michael E. Porter, Redefining Global
Health-Care Delivery, 382 LANCET 1060 (2013) (discussing the emerging global movement
for health rights realization, including the right to treatment with essential medicines and the
right for holistic systems of care, from rights holders’ perspectives).
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this mapping, the first level is the “micro” or local governmental jurisdiction. The second level is the “mid-level” or national, and the third
level is the “macro” or international and transnational. The challenge
here is to keep all three of these legal/social/cultural domains in view
and acknowledging their jurisdictions, while at the same time engaging
with the potential synergies among them. This involves ongoing motion and interaction from one to another at the same time. Thus, the
vision to the solution must be ecological rather than categorical. Without such a way of seeing it, is all too easy to imagine “solutions” to a
multi-dimensional challenge in terms of dichotomies. For example, it
becomes too tempting to understand the “right” to essential medicines
as a question of inadequate international intellectual property regimes,
dysfunctional national delivery systems, corrupt local officials, or
greedy pharmaceutical conglomerates, rather than all of the above systems, minus the anthropomorphic adjectives, interacting with one another.
Transcending the micro/mid-level/macro trichotomy is enabled
by embedding the implementation of the essential medicines right into
primary care systems that are in turn nested in wider ecologies of care,
rather than either producing more drugs full stop, or improving international law. An image of ecologies of care in turn suggests new points
where scholars and advocates can enter into the essential medicines/health rights domain. Asking for more and cheaper drugs from
big pharmaceutical companies may feel cathartic. The demand might
fuel social anger. But it will not help untangle the intricate webs of law
that configure both big pharmaceuticals’ power and the dynamics
through which that power in turn disempowers the lowest income people who need health care.
Such webs of law do not just include the WHO’s 2015 essential
medicines list. And they do not just include international intellectual
property law and the WTO. The webs also include bilateral investment
treaties, international tax treaties, global financial arrangements, local
organizing activities, and laws that govern antitrust and incorporation
that might be used either to facilitate—or to obstruct—the formation
of huge health care conglomerates in low income communities as well
as wealthy nations.
Further attention must also be paid to the webs of laws, both national and international, that could be put in place to enable the emergence of health systems more adequate to offer good care in low income nations. Such laws might include frameworks to incentivize the
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adaptation of diagnostic and treatment modalities designed for rich nations’ but adaptable for use in less-resourced settings. A final domain
that warrants creative attention is the loss of medical workers —both
professional and lay—from health sites already depleted of material
resources. This drain is taking place across rich and poor regions of
developed nations as well as across north/south borders in the global
south.77 How can cross-regional and cross-national partnerships target
funding and configure workable laws to address these inequitable geographies in a world where income inequality is everywhere? Once the
micro/mid-level/macro blinders are loosened and the map becomes
more nuanced, one opportunity suggests another. It will take collaborative work to fill in all of the domains.
IV. BACK TO THE CHALLENGE OF MENTAL HEALTH CARE
A capacious vision of health rights/essential medicines is needed
in every domain including the epicenter of the essential medicines focus so far, that is the fight against infectious disease. Yet, that said, the
need is starkly apparent in the case of mental health care. Indeed, the
mental health challenge is a “canary in the coal mine” with respect to
the urgent need for a different kind of essential medicines/human rights
activism in every health domain. For the mental health challenge, both
in the United States and in developing nations, exposes the fact that
maintaining all people’s highest level of well-being is a “chronic” endeavor. For every disease, and every person, this task is an ongoing
practice of care.
Here are just a few features of that challenge. The first is obtaining adequate funding. That should go without saying. For you cannot
calm A’s agitation on an ongoing basis without the drugs, staff, technologies, and equipment that can help. Indeed, in part because of activist effort, the health financing systems in many developing nations
were pushed beyond a scheme that required even people with little or
no cash income nonetheless to pay cash before treatment even for urgent health needs. Today, in Ghana for instance, health care is financed
by a generous national health insurance scheme.78 The scheme includes
the right to a long list of medications for those who can afford to pay

77. See Gamal I. Serour, Healthcare Workers and the Brain Drain, 106 INT’L J.
GYNECOLOGY & OBSTETRICS 175 (2009).
78. See National Health Insurance Act (Act No. 852/2012) (Ghana); About Us: Brief Introduction to the NHIS, NAT’L HEALTH INS. SCHEME, http://www.nhis.gov.gh/about.aspx (last
visited Mar. 15, 2016).
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premiums and registration fees.79 Yet if they cannot pay, then the national Mental Health Act and National Health Insurance Act provide
that mental health patients are entitled to receive free needed medications as well as free care.80
The current Mental Health Act81 was revised from the prior colonial version only in 2012. It authorizes the creation of a special taxfinanced fund earmarked for mental health expenditures for multiple
types of care.82 Yet even if this fund becomes large, most of its proceeds are likely to be targeted to national level tertiary services in existing psychiatric hospitals, the training of high-level professionals,
and the like. The fund is not nearly as likely to fund Alma Ata-inspired
networks of ground-level services embedded in wider fabrics of care.
It is the lack of such networks that could make a great difference
in the case of A and the many others who, like her, are challenged by
mental—and somatic— health conditions. Let us take her situation as
the example and assume that the lithium and backup medications she
needs are already available in primary care settings in all geographic
regions. She still needs at least three more conditions in place to ensure
her right to high quality care. First, she needs access to the equipment
and capacity to have those drugs administered where she actually is on
an ongoing basis, on the ground. Thus, in the case of lithium and many
other drugs, she needs the clinic, and her home, to have access to clean
needles, clean water, skin disinfectants, and trained people to draw the
blood and read the results. If all of these capacities cannot be accommodated, then alternative testing methods must be adapted to work in
less-resourced settings.
Second, she needs supplemental treatments tailored to the challenges she faces along with the agitation, like therapies for the overwhelming sensory input, social stress, and sleep deprivation, which can
spiral into further agitation. These treatments, as well as basic mental
health education, are critical for guarding against both stigma, and the
self-stigma, that can lead to self-doubt, despair, and exploitation. They
must be available for her, her family, and her neighbors through local
health advocates and community volunteers. For without such practices (although they can arguably be called “medicines”), all the drugs
that money can buy are unlikely to cure or even manage either mental

79.
80.
81.
82.

See supra note 10.
See supra note 9.
Mental Health Act of 2012 (Act No. 846/2012).
Id. §§ 80–85.
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health conditions or indeed any other health challenge.
Third, A and all others with health conditions need people to be
there in whatever ways that are feasible under the circumstances.
These must include highly trained mental health professionals who design, manage, monitor, and realize whole systems of care and provide
its most technologically “high-level” care. I might underscore here that
though Ghana, for instance, has too few of these people in numbers, its
mental health leadership team has worldwide renown.83 But such
highly trained people are not the only caring people that health-challenged people need around them to thrive. They also need people at the
primary care and mobile outreach levels, community and family volunteers, peer supporters, spiritual counselors, paralegal advocates, and
more. All of these must be trained to work together and drawn together
into caring teams. These networks of care must be complemented by
networks in civil society, all working together on public education;
peer and family activism; policy advocacy; and anti-stigma campaigns.
Without this dimension of the work, the political will to maintain robust legal frameworks for health funding, patient crisis management,
and front line care will erode. Fearful, exploitive responses to health
challenges, be they cancer, epilepsy, polio, or mental health conditions,
for instance, will continue, and the work of health providers and family
members themselves, as they try to cope, can become a target of human
rights chastisement and shaming on a global stage.
These objectives echo the Alma Ata Declaration and the earlier
practices it drew from. Furthermore, these objectives are belatedly being “found” to be “evidence-based” and thus drawn upon in primary
health care design in rich but unequal nations like the United States.
Furthermore, such practices are proving effective in managing other
NCDs and even infectious diseases, among all socioeconomic groups
in all regions of the globe.84
It is incumbent on the essential medicines/health rights movement
to keep up with these developments. Chemicals must be re-conceptualized as just one part of the networks of care that are required and
must therefore be designed, resourced, and put in place, in order to
deliver the treatments consistent with all people’s highest attainable
83. For instance, the Chief Psychiatrist of the Ghana Health Service, Dr. Akwasi Osei,
has long been a faculty member at the WHO-sponsored global university program on mental
health and human rights located each year in Pune, India. See Indian Law Society & WHO,
International Diploma in Mental Health Law and Human Rights 2011–2012, at 4, 25,
http://enil.eu/wp-content/uploads/2011/06/Prospectus-2011-12.pdf.
84. See Rebecca Onie, Paul Farmer, & Heidi Behforouz, Realigning Health with Care,
STAN. SOC. INNOVATION REV., Summer 2012, at 28.
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level of mental and physical health. We need to move beyond an obsession with intellectual property reform as the only key to essential
medicine rights and toward understanding that decreasing the cost of
expensive drugs is but a single part of what it will take to deliver the
essentials of rights-based care. For within the “coal mine” of mental
health care, unpatented, inexpensive, and widely available medication
is both already there and not yet fully accessed, and that is a comprehensive circle. To realize the human rights to essential medicines, we
need to draw our work toward it and bring it into reach.

